Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

Author

  • Gerald Watts
2019

Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis of Interventional Studies

Pirro, M., Simental-Mendia, L. E., Bianconi, V., Watts, G. F., Banach, M. & Sahebkar, A., Jan 2019, In : Journal of Clinical Medicine. 8, 1, 14 p., 118.

Research output: Contribution to journalReview article

Open Access
2015

Statins and Mipomersen: Mechanisms of Action and Patient Tolerability

Pang, J., Chan, D. & Watts, G., 2015, Combination Therapy in Dyslipidemia. Banach, M. (ed.). Switzerland: Springer International Publishing, p. 73-86

Research output: Chapter in Book/Conference paperChapter

1 Citation (Scopus)

Contemporary and Novel Therapeutic Options for Hypertriglyceridemia

Bell, D. A. & Watts, G. F., 1 Dec 2015, In : Clinical Therapeutics. 37, 12, p. 2732-2750 19 p.

Research output: Contribution to journalLiterature review

5 Citations (Scopus)
2013

New LDL-cholesterol lowering therapies: Pharmacology, clinical trials, and relevance to acute coronary syndromes

Sahebkar, A. H. & Watts, G., 2013, In : Clinical Therapeutics. 35, 8, p. 1082-1098

Research output: Contribution to journalReview article

92 Citations (Scopus)
2011
8 Citations (Scopus)
2012
15 Citations (Scopus)
2018

Lipoprotein(a): lodestar for future clinical trials

Watts, G. F. & Boffa, M. B., 13 Oct 2018, In : The Lancet. 392, 10155, p. 1281-1282 2 p.

Research output: Contribution to journalComment/debate

5 Citations (Scopus)
2014

Cigarette smoking and albuminuria are associated with impaired arterial smooth muscle function in patients with type 2 diabetes mellitus: A FIELD substudy

Harmer, J. A., Keech, A. C., Veillard, A. S., Skilton, M. R., Marwick, T. H., Watts, G., Meredith, I. T. & Celermajer, D., Nov 2014, In : Diabetes Research and Clinical Practice. 106, 2, p. 328-336 9 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)
2017

Systematic Screening for Familial Hypercholesterolaemia and Elevated Lp (a) in Families

Ellis, K. L., Pang, J., Bell, D. A., Hooper, A. J., Burnett, J. R. & Watts, G. F., 2017, In : Heart, Lung and Circulation. 26, Supp. 2, p. S121-S122

Research output: Contribution to journalAbstract/Meeting Abstract

2019

Cost-effectiveness of screening and treating children with familial hypercholesterolemia early in life from a Dutch healthcare perspective

Ademi, Z., Norman, R., Pang, J., Ference, B., Liew, D., Sijbrands, E., Watts, G. & Wiegman, A., Nov 2019, In : Value in Health. 22, Supplement 3, p. S405-S405 1 p., CC1.

Research output: Contribution to journalAbstract/Meeting Abstract

2017

Isolated Elevation of Lipoprotein(A) is Uncommon Among Patients Admitted to Coronary Care

Ellis, K. L., Pang, J., Bell, D. A., Burnett, J. R., Schultz, C., Hillis, G. S. & Watts, G. F., 2017, In : Heart, Lung and Circulation. 26, Supp. 2, p. S84 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2013
Open Access
17 Citations (Scopus)
2011

Rosiglitazone does not improve vascular function in subjects with chronic kidney disease

Chan, D. T., Watts, G., Irish, A. & Dogra, G., 2011, In : Nephrology Dialysis Transplantation. 26, p. 3543–3549

Research output: Contribution to journalArticle

19 Citations (Scopus)
2018

Rationale and design of a trial to personalize risk assessment in familial coronary artery disease

Marwick, T. H., Whitmore, K., Nicholls, S. J., Stanton, T., Mitchell, G., Tonkin, A., Blizzard, C., Neil, A., Jones, C., Watts, G. F. & CAUGHT-CAD Investigators, 1 May 2018, In : American Heart Journal. 199, p. 22-30 9 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2014

Interrelationships between the kinetics of VLDL subspecies and hdl catabolism in abdominal obesity: A multicenter tracer kinetic study

Vergès, B. L., Adiels, M., Borén, J. B., Barrett, H., Watts, G., Chan, D., Duvillard, L., Söderlund, S., Matikainen, N., Kahri, J., Robin, I. & Taskinen, M. R., 2014, In : Journal of Clinical Endocrinology and Metabolism. 99, 11, p. 4281-4290

Research output: Contribution to journalArticle

Open Access
13 Citations (Scopus)
2018
6 Citations (Scopus)
2016

ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity

Verges, B., Adiels, M., Borén, J., Barrett, H., Watts, G., Chan, D., Duvillard, L., Soderlund, S., Matikainen, N., Kahri, J., Lundbom, N., Lundbom, J., Hakkarainen, N., Aho, S., Simoneau-Robin, I. & Taskinen, M. R., 1 Apr 2016, In : Journal of Clinical Endocrinology and Metabolism. 101, 4, p. 1398-1406 9 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)
2011

Whither the lipid profile: feast, famine, or no free lunch?

Watts, G. F. & Cohn, J. S., Mar 2011, In : Clinical Chemistry. 57, 3, p. 363-365 3 p.

Research output: Contribution to journalEditorial

10 Citations (Scopus)
2015

Prevalence and treatment of familial hypercholesterolaemia in Australian communities

Watts, G., Shaw, J. E., Pang, J., Magliano, D. J., Jennings, G. L. R. & Carrington, M. J., 2015, In : International Journal of Cardiology. 185, p. 69-71

Research output: Contribution to journalArticle

48 Citations (Scopus)
2011
5 Citations (Scopus)
2013

Dietary fatty acids and lipoprotein metabolism: New insights and updates

Ooi, E., Ng, T. W., Watts, G. & Barrett, H., 2013, In : Current Opinion in Lipidology. 24, 3, p. 192-197

Research output: Contribution to journalReview article

33 Citations (Scopus)
2018

Squaring up the health economics of PCSK9 monoclonal antibodies ‘down under’

Watts, G. F. & Norman, R., 15 Sep 2018, In : International Journal of Cardiology. 267, p. 193-194 2 p.

Research output: Contribution to journalEditorial

3 Citations (Scopus)
2016

Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes

Negrulj, R., Mooranian, A., Chen-Tan, N., Al-Sallami, H. S., Mikov, M., Golocorbin-Kon, S., Fakhoury, M., Watts, G., Arfuso, F. & Al-Salami, H., 2016, In : Artificial Cells, Nanomedicine and Biotechnology. 44, 5, p. 1290-1297

Research output: Contribution to journalArticle

19 Citations (Scopus)
2019

A window into the heart of familial hypercholesterolaemia in the community

Watts, G. F. & Pang, J., 1 May 2019, In : The Lancet Public Health. 4, 5, p. e216-e217

Research output: Contribution to journalEditorial

Open Access
2015

Evolocumab in the treatment of dyslipidemia: Pre-clinical and clinical pharmacology

Page, M. M. & Watts, G., 2015, In : Expert Opinion on Drug Metabolism & Toxicology. 11, 9, p. 1505-1515

Research output: Contribution to journalArticle

9 Citations (Scopus)
2018

THE EFFECTS OF OMEGA-3 FATTY ACIDS ON INFLAMMATION, PRO-ATHEROGENIC CYTOKINES AND LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS

Yong, K., Mori, T., Chew, G., Beilin, L., Puddey, I., Watts, G., Irish, A., Dogra, G., Boudville, N. & Lim, W., Sep 2018, In : Nephrology. 23, p. 45-45 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2 Citations (Scopus)
2016
Open Access
8 Citations (Scopus)
2017

Depicting new pharmacological strategies for familial hypercholesterolaemia involving lipoprotein (a)

Vuorio, A., Watts, G. F. & Kovanen, P. T., 2017, In : European Heart Journal. 38, 48, p. 3555-3559 7 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)
2011

Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient?

Watts, G. F. & Karpe, F., Aug 2011, In : Expert Review of Cardiovascular Therapy. 9, 8, p. 987-997 11 p.

Research output: Contribution to journalReview article

7 Citations (Scopus)
2014

Critical review of non-statin treatments for dyslipoproteinemia

Pang, J., Chan, D. & Watts, G., 2014, In : Expert Review of Cardiovascular Therapy. 12, 3, p. 359-371

Research output: Contribution to journalReview article

6 Citations (Scopus)
2019

Response by Ward et al to Letter Regarding Article, "statin Toxicity: Mechanistic Insights and Clinical Implications"

Ward, N. C., Watts, G. F. & Eckel, R. H., 7 Jun 2019, In : Circulation Research. 124, 12, p. e121-e122

Research output: Contribution to journalLetter

2 Citations (Scopus)
2016

International developments in the care of familial hypercholesterolemia: Where now and where to next?

Pang, J., Lansberg, P. J. & Watts, G. F., 2016, In : Journal of Atherosclerosis and Thrombosis. 23, 5, p. 505-519 15 p.

Research output: Contribution to journalReview article

27 Citations (Scopus)
2014
25 Citations (Scopus)
2018

Editorial introductions (in Current Opinion in Lipidology)

Stroes, E. S. G. & Watts, G. F., Dec 2018, In : Current Opinion in Lipidology. 29, 6, p. 433-433 1 p.

Research output: Contribution to journalEditorial

2019
Open Access
7 Citations (Scopus)
2014

Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation

Watts, G., Gidding, S. S., Wierzbicki, A. S., Tóth, P. P., Alonso, R. M., Brown, W. V., Bruckert, E., Defesche, J. C., Lin, K., Livingston, M. C. P., Mata, P., Parhofer, K. G., Raal, F. J., Santos, R. D., Sijbrands, E. J., Simpson, W. G., Sullivan, D. R., Susekov, A. V., Tomlinson, B. T., Wiegman, A. & 2 others, Yamashita, S. & Kastelein, J. J. P., 2014, In : Journal of Clinical Lipidology. 8, 2, p. 148-172

Research output: Contribution to journalReview article

71 Citations (Scopus)
2013

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia

Grundy, S. M., Expert Dyslipidemia Panel & Watts, G., 2013, In : Journal of Clinical Lipidology. 7, 6, p. 561-565 5 p.

Research output: Contribution to journalReview article

84 Citations (Scopus)
2018

PCSK9 monoclonal antibody on a knife-edge: An article of faith in FH?

Ward, N. C. & Watts, G. F., 1 Jul 2018, In : Journal of Clinical Lipidology. 12, 4, p. 844-848 5 p.

Research output: Contribution to journalEditorial

2016
3 Citations (Scopus)
2014

Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol

Mooranian, A., Negrulj, R., Chen-Tan, N. W., Al-Sallami, H. S., Fang, Z., Mukkur, T. K. S., Mikov, M. M., Goločorbin-Kon, S., Fakhoury, M., Watts, G., Matthews, V., Arfuso, F. & Al-Salami, H., 2014, In : Drug Design, Development and Therapy. 8, p. 1221-1230

Research output: Contribution to journalArticle

Open Access
35 Citations (Scopus)
2018
7 Citations (Scopus)
2016
21 Citations (Scopus)

Awareness of Pre-diabetes or Diabetes and Associated Factors in People With Psychosis

Foley, D. L. L., Mackinnon, A., Morgan, V. A., Watts, G. F., Castle, D. J. J., Waterreus, A. J. & Galletly, C. A. A., 2016, In : Schizophrenia Bulletin. 42, 5, p. 1280-1289 10 p.

Research output: Contribution to journalArticle

Open Access
5 Citations (Scopus)
2012

Cardiometabolic risk factors in people with psychotic disorders: The second Australian national survey of psychosis

Galletly, C. A., Foley, D. L., Waterreus, A., Watts, G., Castle, D., Mcgrath, J. J., Mackinnon, A. & Morgan, V., 2012, In : Australian and New Zealand Journal of Psychiatry. 46, 8, p. 753-761

Research output: Contribution to journalArticle

126 Citations (Scopus)
2015

Cardiovascular risk factor associations in adults with psychosis and adults in a national comparator sample

Foley, D. L., Mackinnon, A., Morgan, V., Watts, G., Shaw, J. E., Magliano, D. J., Castle, D. J., Mcgrath, J. J., Waterreus, A. & Galletly, C. A., Aug 2015, In : Australian and New Zealand Journal of Psychiatry. 49, 8, p. 714-723

Research output: Contribution to journalArticle

10 Citations (Scopus)
2016
5 Citations (Scopus)
2017

Statins, PCSK9 inhibitors and cholesterol homeostasis: a view from within the hepatocyte

Sniderman, A. D., Kiss, R. S., Reid, T., Thanassoulis, G. & Watts, G. F., 1 May 2017, In : Clinical Science. 131, 9, p. 791-797 7 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2019

Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia

Pérez de Isla, L., Ray, K. K., Watts, G. F., Santos, R. D., Alonso, R., Muñiz-Grijalvo, O., Diaz-Diaz, J. L., Badimon, L., Catapano, A. L. & Mata, P., 1 Jul 2019, In : Atherosclerosis. 286, p. 40-45 6 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)